Conmed Stock Alpha and Beta Analysis

CNMD Stock  USD 73.16  0.73  0.99%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as CONMED. It also helps investors analyze the systematic and unsystematic risks associated with investing in CONMED over a specified time horizon. Remember, high CONMED's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CONMED's market risk premium analysis include:
Beta
1.04
Alpha
(0.07)
Risk
2.47
Sharpe Ratio
0.0133
Expected Return
0.0328
Please note that although CONMED alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, CONMED did 0.07  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of CONMED stock's relative risk over its benchmark. CONMED has a beta of 1.04  . CONMED returns are very sensitive to returns on the market. As the market goes up or down, CONMED is expected to follow. At present, CONMED's Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 4.23, whereas Enterprise Value Over EBITDA is forecasted to decline to 19.14.

Enterprise Value

819.63 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out CONMED Backtesting, CONMED Valuation, CONMED Correlation, CONMED Hype Analysis, CONMED Volatility, CONMED History and analyze CONMED Performance.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

CONMED Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CONMED market risk premium is the additional return an investor will receive from holding CONMED long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CONMED. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CONMED's performance over market.
α-0.07   β1.04

CONMED expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of CONMED's Buy-and-hold return. Our buy-and-hold chart shows how CONMED performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

CONMED Market Price Analysis

Market price analysis indicators help investors to evaluate how CONMED stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CONMED shares will generate the highest return on investment. By understating and applying CONMED stock market price indicators, traders can identify CONMED position entry and exit signals to maximize returns.

CONMED Return and Market Media

The median price of CONMED for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 71.75 with a coefficient of variation of 6.61. The daily time series for the period is distributed with a sample standard deviation of 4.66, arithmetic mean of 70.43, and mean deviation of 4.02. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Investors in CONMED have unfortunately lost 43 percent over the last three years
09/04/2024
2
Disposition of 1000 shares by Charles Farkas of CONMED at .64 subject to Rule 16b-3
09/05/2024
 
CONMED dividend paid on 4th of October 2024
10/04/2024
3
Heres Why You Should Retain CONMED Stock in Your Portfolio
10/07/2024
4
Is CONMED Corporation the Most Profitable Small-Cap Stock to Invest In
10/29/2024
5
Acquisition by Todd Garner of 22727 shares of CONMED subject to Rule 16b-3
11/01/2024
6
Insider Trading
11/04/2024
7
Disposition of 24303 shares by Curt Hartman of CONMED at 74.76 subject to Rule 16b-3
11/07/2024
8
Heres Why Conmed is a Strong Growth Stock
11/08/2024
9
Capital Research Global Investors Adjusts Stake in Conmed Corp
11/13/2024
10
Conmed is a Top-Ranked Momentum Stock Should You Buy
11/15/2024
11
Disposition of 118 shares by Richard Glaze of CONMED at 70.69 subject to Rule 16b-3
11/20/2024
12
Conmed Corp Trading Down 3.4 percent on Nov 26
11/26/2024

About CONMED Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CONMED or other stocks. Alpha measures the amount that position in CONMED has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.0056260.0089980.0072960.0136
Price To Sales Ratio4.092.552.72.83

CONMED Upcoming Company Events

As portrayed in its financial statements, the presentation of CONMED's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CONMED's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CONMED's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CONMED. Please utilize our Beneish M Score to check the likelihood of CONMED's management manipulating its earnings.
31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with CONMED

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:
Check out CONMED Backtesting, CONMED Valuation, CONMED Correlation, CONMED Hype Analysis, CONMED Volatility, CONMED History and analyze CONMED Performance.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
CONMED technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CONMED technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CONMED trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...